Cyrus IL-22 Fusion Protein

About Cyrus Biotechnology

Cyrus Biotechnology is a private, preclinical-stage biotech leveraging a proprietary computational protein design platform to discover and develop novel biologics. The company has validated its platform through over 30 discovery programs with partners and is advancing a focused internal pipeline targeting large markets in autoimmune diseases. Its core strategy involves computationally optimizing natural proteins, such as enzymes and cytokines, to create therapeutics with superior pharmacological properties.

Therapeutic Areas